Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2018
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune HepatitisYnto S de Boer, Alessio Gerussi, Floris F van den Brand, et al.
Frontiers in Immunology|December 28, 2020
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4Neil Halliday, Cayman Williams, Alan Kennedy, et al.
Digestive Diseases and Sciences|May 17, 2022
Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging StigmaCharlotte Lloyd, Jessica Leighton, Lin Lee Wong, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 21, 2022
Outcomes After Liver Transplantation With Incidental CholangiocarcinomaNawaz Z Safdar, Abdul R Hakeem, Rosemary Faulkes, et al.
Cell|September 7, 2005
Identification of an intestinal heme transporterMajid Shayeghi, Gladys O Latunde-Dada, Jonathan S Oakhill, et al.
Frontiers in Immunology|September 25, 2024
Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre studyHeba M Bintalib, Sofia Grigoriadou, Smita Y Patel, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Blood|February 5, 2017
Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutationsTie Zheng Hou, Nisha Verma, Jennifer Wanders, et al.
Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
Pageof 4